Billy Chabalenge
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 9
- Health 6
- Vaccine Coverage and Hesitancy 6
- Co-authors
- Scott Kaba Matafwali (22 shared papers)Steward Mudenda (35 shared papers)Victor Daka (24 shared papers)Webrod Mufwambi (18 shared papers)Ruth Lindizyani Mfune (17 shared papers)Bwalya A. Witika (4 shared papers)Aubrey Chichonyi Kalungia (4 shared papers)Maisa Kasanga (12 shared papers)
- Journals
- Vaccines (2 papers)Crystal Growth & Design (1 paper)BMC Public Health (1 paper)Nanomaterials (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- ZambiaUnited KingdomChina
In The Last Decade
Billy Chabalenge
34 papers receiving 415 citations
Peers
Comparison fields: 5 of 81
- Applied Microbiology and Biotechnology 164
- Molecular Medicine 75
- Geriatrics and Gerontology 25
- Health 35
- Pollution 49
Countries citing papers authored by Billy Chabalenge
This map shows the geographic impact of Billy Chabalenge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Chabalenge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Chabalenge more than expected).
Fields of papers citing papers by Billy Chabalenge
This network shows the impact of papers produced by Billy Chabalenge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Chabalenge. The network helps show where Billy Chabalenge may publish in the future.
Co-authors
The 25 scholars most cited alongside Billy Chabalenge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 85 | |
| 2 | 2023 | 56 | |
| 3 | 2022 | 31 | |
| 4 | 2023 | 28 | |
| 5 | 2022 | 18 | |
| 6 | 2022 | 18 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2024 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2021 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 8 | |
| 19 | 2023 | 8 | |
| 20 | 2023 | 7 |
About Billy Chabalenge
Billy Chabalenge is a scholar working on Applied Microbiology and Biotechnology, Health, Economics and Econometrics, Infectious Diseases and Clinical Psychology, having authored 39 papers that have together received 441 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Vaccine Coverage and Hesitancy (6 papers), COVID-19 and Mental Health (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Essential Oils and Antimicrobial Activity (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Pneumonia and Respiratory Infections (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (164 citations), Molecular Medicine (75 citations), Geriatrics and Gerontology (25 citations), Health (35 citations) and Pollution (49 citations). Billy Chabalenge has collaborated with scholars based in Zambia, United Kingdom and China. Frequent co-authors include Scott Kaba Matafwali, Steward Mudenda, Victor Daka, Webrod Mufwambi, Ruth Lindizyani Mfune, Bwalya A. Witika, Aubrey Chichonyi Kalungia, Maisa Kasanga, Chiluba Mwila and Pedzisai A. Makoni. Their work appears in journals such as Vaccines, Crystal Growth & Design, BMC Public Health, Nanomaterials and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.